Evaluation of the Serum Levels of Interleukin-6, Interleukin-10, and C-Reactive Protein in Iraqi Women with Breast Cancer-Reference-Cited by-同舟云学术

Evaluation of the Serum Levels of Interleukin-6, Interleukin-10, and C-Reactive Protein in Iraqi Women with Breast Cancer

Published:2023-12-31 Issue:3 Volume:15 Page:36-40
ISSN:2311-6544
Container-title:Al-Kufa University Journal for Biology
language:
Short-container-title:Kufa Jour. Bio.

Author:

Ibraheem Muhesin Ashjan,Abbas Hadi Abdul-Hadi

Abstract

Breast cancer is the most prevalent form of cancer in women and is the leading cause of global cancer-related mortality. The study aimed to assess the changes in some serum biomarkers linked to immunity responses in Iraqi breast cancer patients and understand their multifaceted role in the disease's progression. The current investigation comprised a cohort of 55 women diagnosed with breast cancer and a control group of 45 healthy participants. The levels of interleukin-6 (IL-6), interleukin-10 (IL-10), and C-reactive protein (CRP) were estimated in the serum of breast cancer patients. The results showed that patients with breast cancer had a significant increase (p<0.05) in IL-6, IL-10, and CRP serum concentrations as compared to healthy women. These findings give support to the evidence suggesting that these markers may play an essential role in the progression of breast cancer.

Publisher

University of Kufa

Reference27 articles.

1. American Cancer Society (ACS) (2018). Global Cancer: Facts and Figures. American Cancer Society report. 4th Edition. Atlanta. US. No. 861818.

2. American Cancer Society (2023). Cancer Facts & Figures 2023. American Cancer Society report. Atlanta.US.cancer.org | 1.800.227.2345.

3. Lamy, P.J., Durigova, A., & Jacot, W. (2014). Iron homeostasis and anemia markers in early breast cancer. Iron and breast cancer. Clinica Chimica Acta, 434:34-40.

4. Sheikhpour, E., Noorbakhsh, P., Foroughi, E., Farahnak, S., Nasiri, R., et al. (2018). A survey on the role of interleukin-10 in breast cancer: A narrative. Reports of Biochemistry & Molecular Biology, 7(1): 30-37.

5. Chen, J., Wei, Y., Yang, W., Huang, Q., Chen, Y., et al. (2022). IL-6: the link between inflammation, immunity and breast cancer. Frontiers in Oncology, 12:1-11.